Inicio › Carcinoma de células escamosas de cabeza y cuello › Oklahoma › Oklahoma City
Ensayos clínicos de Carcinoma de células escamosas de cabeza y cuello en Oklahoma City, OK
13 estudios para Carcinoma de células escamosas de cabeza y cuello buscan participantes en centros de Oklahoma City y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
ReclutandoFase 3
- University of Oklahoma Health Sciences Center, Oklahoma City
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
ReclutandoFase 3
- University of Oklahoma Health Sciences Center, Oklahoma City
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
ReclutandoFase 2
- University of Oklahoma Health Sciences Center, Oklahoma City
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
ReclutandoFase 3
- Stephenson Cancer Center, Oklahoma City
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
ReclutandoFase 2
- University of Oklahoma Health Sciences Center, Oklahoma City
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
ReclutandoFase 2
- University of Oklahoma Health Sciences Center, Oklahoma City
- Mercy Hospital Oklahoma City, Oklahoma City
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
ReclutandoFase 1
- Normunity Investigational Site, Oklahoma City
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
ReclutandoFase 2/3
- University of Oklahoma Health Sciences Center, Oklahoma City
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
ReclutandoFase 2
- University of Oklahoma Health Sciences Center, Oklahoma City
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
ReclutandoFase 1/2
- SSM OKC Hightower Clinical, Oklahoma City
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
ReclutandoFase 1
- OU Health University of Oklahoma Medical Center, Oklahoma City
- Stephenson Cancer Center (chemo location), Oklahoma City
- University of Oklahoma Health Science Center, Oklahoma City
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
ReclutandoFase 1
- Dren Investigational Site, Oklahoma City
A Study of NX-1607 in Adults With Advanced Malignancies
ReclutandoFase 1
- University of Oklahoma, Oklahoma City
Ensayos de Carcinoma de células escamosas de cabeza y cuello en otras ciudades
- Houston, TX47 estudios
- Los Angeles, CA42 estudios
- Boston, MA40 estudios
- Nashville, TN39 estudios
- New York City, NY39 estudios
- St. Louis, MO28 estudios
- Arlington, VA26 estudios
- Chicago, IL26 estudios
- Philadelphia, PA26 estudios
- Atlanta, GA24 estudios
- San Antonio, TX22 estudios
- Pittsburgh, PA22 estudios
Otros estudios en Oklahoma City
- Cáncer de pulmón de células no pequeñas28 estudios
- Cáncer de ovario28 estudios
- Cáncer de endometrio25 estudios
- Cáncer del colon y del recto22 estudios
- Cáncer de próstata21 estudios
- Cáncer de pulmón19 estudios
- Cáncer de seno17 estudios
- Cáncer metastásico16 estudios
- Cáncer (todos los tipos)14 estudios
- Leucemia mielógena aguda14 estudios
- Cáncer de vejiga11 estudios
- Cáncer de páncreas11 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.